Wolters Kluwer Health
may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
your express consent. For more information, please refer to our Privacy Policy.

Abstract:

In Brief:

Dexamethasone intravitreal implant may present an alternative option in the treatment of chronic diabetic macular edema nonresponsive to three consecutive monthly injections of bevacizumab administered previously. Intraocular pressure measures were only slightly increased. It seems that the effect of dexamethasone may last till 4 months after the initial injection.